Dipan Mehta of Elixir Equities notes a mixed earnings season with disappointments in major sectors like banking and software. However, urban consumption shows promising signs in QSR, retail, hospitality, healthcare, and travel. Mehta advises selectivity, favoring pharma companies with differentiated models, particularly CDMOs, while remaining cautious due to potential tariff impacts and base effects.
Sebi launches new verification agency to crack down on mis-selling
Sebi has launched the Past Risk and Return Verification Agency (PaRRVA) to combat mis-selling of investment products. This tech-driven system, linking credit rating agencies and